A Phase I, Open-Label, Randomized, Crossover Trial in 20 Healthy Subjects to Investigate the Pharmacokinetic Interactions Between the Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir.

Trial Profile

A Phase I, Open-Label, Randomized, Crossover Trial in 20 Healthy Subjects to Investigate the Pharmacokinetic Interactions Between the Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs Efavirenz; Telaprevir; Tenofovir disoproxil fumarate
  • Indications Hepatitis C; HIV infections
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Janssen R&D Ireland
  • Most Recent Events

    • 16 Jun 2009 Actual end date (April 2009) added as reported by ClinicalTrials.gov.
    • 16 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Feb 2009 Additional location identified as reported by ClinicalTrials.gov, last updated 27-2-2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top